Next Article in Journal
Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses
Next Article in Special Issue
Circularized Nanodiscs for Multivalent Mosaic Display of SARS-CoV-2 Spike Protein Antigens
Previous Article in Journal
New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review
Previous Article in Special Issue
Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix® and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection
 
 
Article

Article Versions Notes

Vaccines 2023, 11(10), 1572; https://doi.org/10.3390/vaccines11101572
Action Date Notes Link
article xml file uploaded 9 October 2023 05:18 CEST Original file -
article xml uploaded. 9 October 2023 05:18 CEST Update https://www.mdpi.com/2076-393X/11/10/1572/xml
article pdf uploaded. 9 October 2023 05:18 CEST Version of Record https://www.mdpi.com/2076-393X/11/10/1572/pdf
article html file updated 9 October 2023 05:20 CEST Original file https://www.mdpi.com/2076-393X/11/10/1572/html
Back to TopTop